Ferring Italy

Created in the early 2000s, Ferring Italy now has a strong position both in terms of pipeline and balance sheet. It counts 54 sales reppresentatives and a has turnover of 50 million euros per year.

Its operations in Italy are divided into three main business units respectively dedicated to infertility, Inflammatory Bowen Diseases (IBD) and endocrino-urology, yet all linked by the peptide research.

Phase III studies are managed at the local level, and Ferring Italy is currently working with 15 hospitals involved in the Phase III trials of Firmagon.
Address: Via Senigallia 18/2, 20161 Milan
Website: http://www.ferring.com
Phone: +39 02 640 00 11
Fax: +39 02 640 00 120
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.